Cytosorbents Corporation logo

Cytosorbents Corporation

CTSO | NASDAQ
Chart Builder DCF Calculator
$5.57
+$0.06 (+1.09%)
Sep 22, 2026, 9:41 AM ET · Market open

Market Data

Market Cap
$17.31M
Enterprise Value
$39.23M
Beta
1.34
Average Volume
81.39K
Shares Outstanding (Diluted)
3.14M
Shares Change YoY
-6.49%
Institutional Ownership
26.87%
Exchange
NASDAQ
ISIN
US23283X2062

Price Performance

Price Change 1M
-21.3%
Price Change 3M
-35.8%
Price Change 6M
-59.0%
Price Change YTD
-58.0%
Price Change 1Y
-71.5%
Price Change 3Y
-86.1%
Price Change 5Y
-96.6%
1M CAGR (ann.)
-23.5%
1Y CAGR (ann.)
-70.5%
5Y CAGR (ann.)
-49.8%
All-Time CAGR
-21.2%

Valuation

PE Ratio
-0.96
Forward PE
15.48
PEG Ratio
0.01
Forward PEG
0.01
PS Ratio
0.47
Forward PS
0.40
PB Ratio
-23.05
P/FCF Ratio
-1.66
P/Adj. FCF Ratio
-1.30
P/OCF Ratio
-1.68
EV/Sales
1.05
EV/EBIT
-2.53
EV/EBITDA
-2.78
EV/FCF
-3.76
Earnings Yield
-104.4%
FCF Yield
-60.2%
Adj. FCF Yield
-76.7%

Financial Health

Net Debt
$21.92M
Total Debt
$26.33M
Cash & Short-Term Investments
$4.41M
Total Assets
$37.96M
Current Ratio
0.66
Quick Ratio
0.50
Debt / Equity Ratio
-35.07
Debt / EBITDA
-1.86
Debt / FCF
-2.53
OCF / Debt
-0.39
Interest Coverage
-8.86
Altman Z-Score
-12.23
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
71.6%
Operating Profit Margin
-33.4%
EBITDA Margin
-38.0%
Net Profit Margin
-48.9%
FCF Margin
-28.0%
Adj. FCF Margin
-35.7%
SBC / Revenue
7.7%
SBC Impact (per share)
-27.4%

Returns

Return on Assets
-48.0%
Return on Equity
-445.1%
Return on Invested Capital
-42.4%
Return on Capital Employed
-89.1%
Return on Tangible Assets
-51.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
2.3%
Revenue CAGR 5Y
-3.2%
Revenue CAGR 10Y
20.0%
EPS CAGR 3Y
36.1%
EPS CAGR 5Y
30.9%
EPS CAGR 10Y
2.9%
FCF CAGR 3Y
40.3%
FCF CAGR 5Y
30.2%
FCF CAGR 10Y
-4.5%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
2
EPS Growth Next 3Y
38.0%
Revenue Growth Next 3Y
13.5%
Earnings Date
Nov 11, 2026
EPS Estimate (next Q)
-$0.90
EPS Growth Est (next Q)
2150.0%
Revenue Est (next Q)
$9.9M
Revenue Growth Est (next Q)
4.4%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$5.38
Price Target Upside
-2.4%

Cash Flow

Operating Cash Flow
$-10.31M
Free Cash Flow
$-10.42M
Adj. Free Cash Flow
$-13.28M
FCF Per Share
-$3.32
OCF Per Share
-$3.28
OCF/S Ratio
-27.7%

Income Statement

Revenue
$37.22M
Gross Profit
$26.65M
Operating Income
$-12.42M
EBITDA
$-14.14M
Net Income
$-18.21M
EPS (Diluted)
-$5.75
Revenue / Employee
$249.77K
Profit / Employee
$-122.23K
Employees
149

© 2026 bestshares.com. All rights reserved.